ValueHealth, Capital Health announce joint venture surgical facility

Listen to this article

ValueHealth LLC, a tech-enabled surgical platform company, announced on Wednesday a joint venture with Pennington-based Capital Health.

The strategic partnership will expand ValueHealth’s market share dominance in the Mid-Atlantic region and position the company for further growth opportunities.

A new Bordentown surgery center will be designated through ValueHealth’s Ambulatory Centers of Excellence (ACE) program with an Advanced Total Joint Certification—meaning it will not only exceed national accrediting standards, but will also meet ValueHealth’s stricter clinical, quality and financial measures.

The facility will serve the needs of Capital Health and the surrounding community, including a growing network of more than 400 employed physicians. And ValueHealth’s digital surgical platform, which includes patient steerage, payor bundles, and warranty contracts, will empower the facility to handle approximately 6,000 cases per year.

The 23,000-square-foot ambulatory surgery center will deliver hyper-specialized, high-value surgical procedures – including total joint replacement – in a state-of-the-art facility with four operating rooms and six recovery StaySuites, which use a proven recovery model to reduce risks for patient readmission and post-operative complications.

“This partnership helps solidify our efforts to provide full market coverage to the larger Philadelphia and New Jersey regions,” said ValueHealth Chairman John Palumbo. “We look for partners who are aligned with our commitment to deliver value-based care with the country’s highest clinical outcomes and unprecedented patient experience while lowering costs for employers and patients. Capital Health is a partner that is aligned clinically, economically, and strategically to serve its community.”

“Board and executive teams are tasked with balancing competing capital priorities: inpatient, outpatient, infrastructure, revenue generation, and new markets core business,” said Capital Health President and Chief Executive Officer Al Maghazehe. “With this expansion, Capital Health’s long-range planning and strategy to broaden our reach into surrounding markets, bringing total joint replacements and other high-acuity procedures to a state-of-the-art outpatient setting, will propel us forward as a health system of the future,” Maghazehe said.

The estimated occupancy date for the Bordentown facility is during the first quarter of 2021.